Crossmark

Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab

Crossref DOI link: https://doi.org/10.1038/s41409-020-01193-7

Published Online: 2021-01-08

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Na

Wang, Yini

Wang, Jingshi

Wu, Lin

Wang, Zhao https://orcid.org/0000-0003-1067-4589
Funding

Funding for this research was provided by:

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201702)
License Information

Text and Data Mining valid from 2021-01-08

Version of Record valid from 2021-01-08
More Information

Article History

Received: 15 September 2020

Revised: 30 November 2020

Accepted: 8 December 2020

First Online: 8 January 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below